Brief report
27 Jan 2021
Brief report
| 27 Jan 2021
Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series
Ernesto Muñoz-Mahamud et al.
Related authors
Related subject area
Subject: Prosthesis-related infections | Topic: Surgery
Cited articles
Bémer, P., Léger, J., Tandé, D., Plouzeau, C., Valentin, A. S.,
Jolivet-Gougeon, A., Lemarié, C., Kempf, M., Héry-Arnaud, G., Bret, L., Juvin,
M. E., Giraudeau, B., Corvec, S., and Burucoa, C.: Centre de Référence des
Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team:
How Many Samples and How Many Culture Media To Diagnose a Prosthetic Joint
Infection: a Clinical and Microbiological Prospective Multicenter Study, J.
Clin. Microbiol., 54, 385–391, https://doi.org/10.1128/JCM.02497-15,
2016.
Dahners, L. E. and Bos, G. D.: Fluorescent tetracycline labeling as an aid to
debridement of necrotic bone in the treatment of chronic osteomyelitis, J
Orthop. Trauma., 16, 345–346, https://doi.org/10.1097/00005131-200205000-00009, 2002.
Duwelius, P. J. and Schmidt, A. H.: Assessment of bone viability in patients with
osteomyelitis: preliminary clinical experience with laser Doppler flowmetry,
J. Orthop. Trauma., 6, 327–332, 1992.
Harvey, B. R., Ephros, H., and Defalco, R. J.: Tetracycline bone labeling in surgical
management of chronic osteomyelitis: a case report, J. Oral Maxillofac. Surg.,
62, 752–754, https://doi.org/10.1016/j.joms.2003.08.036, 2004.